首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
admin
2011-03-10
34
问题
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should include an explanation.
While drug companies have been eager to make public any positive results of their trials, recent revelations suggest they’ve balked at divulging tests when the results are not what they’d hoped to see. The furor has centered around the use Of anti-depressants on children.
The industry has begun to make some moves to address the concerns about drug trials. Drug companies have agreed to set up a voluntary system of posting their drug trials on the Internet. But that seems unlikely to satisfy some members of Congress, who are expected to introduce legislation to establish a mandatory drug registry.
Last week, editors of a dozen influential medical journals announced that they would begin requiring drug companies to post a drug trial in a public database prior to accepting an article about it. Doctors rely on these articles to make treatment choices. The editors hope that the registry will force unfavorable drug studies, before kept secret, into the open.
Medical journals already had been tightening up on the authorship of their articles, insisting that authors declare if they had any conflicts of interest, such as any financial or other ties to the drug company, says Daniel Callahan, a director at the Hastings Center, a nonprofit bioethics research institute in Garrison, N.Y.
Information from previously undisclosed clinical trials could lower prices, reduce the number of badly designed trials, and help doctors considering the use of a drug for a non-approved purpose to know why it hasn’t been approved for that use.
Antidepressant drugs "have some serious side effects ... that seem to be much more common than people realize ... much more common than you might think from seeing drug ads and from reports on drug studies," says Joel Gurin, executive vice president of Consumer Reports. His magazine just finished a survey of readers showing a "dramatic shift from talk therapy to drug therapy for mental health problems" during the past decade. In 1995, less than half of people getting mental health treatment--40 percent--got drug therapy. Today 68 percent receive drug treatment, Mr. Gurin says.
Some studies coming to light show that antidepressants work no better than placebos. Even better than merely registering drug trials, Caplan (director of the Center for Bioethics at the University of Pennsylvania in Philadelphia) suggests, would be to require that a new drug not only be "safe and do what it’s supposed to do", but that it do it as well or better than other drugs already on the market. That, he says, would help push research into new areas and save money.
Who is willingly to introduce the registry of drug trials?
选项
A、The pharmaceutical industry.
B、US Food and Drug Administration.
C、The Congress.
D、The drug companies.
答案
C
解析
下面哪一方是愿意引进药品临床试验结果登记这一方法的?由原文第二段可知,pharmaceutical industry和US Food and Drug Administration都是迫于压力的,更不用说此方法会对其产生不利的药品公司了。
转载请注明原文地址:https://jikaoti.com/ti/azpYFFFM
0
专业英语八级
相关试题推荐
Americansoftentrytosaythingsasquicklyaspossible,soforsomeexpressionsweusethefirstlettersofthewordsinstead
Growingconcernsoverthesafetyandefficacyofanti-depressantdrugsprescribedtochildrenhavecaughttheeyeofCongressan
Growingconcernsoverthesafetyandefficacyofanti-depressantdrugsprescribedtochildrenhavecaughttheeyeofCongressan
IftherewasonethingAmericanshadarighttoexpectfromCongress,itwasafederalplantohelptheelderlypayforprescrip
IftherewasonethingAmericanshadarighttoexpectfromCongress,itwasafederalplantohelptheelderlypayforprescrip
IftherewasonethingAmericanshadarighttoexpectfromCongress,itwasafederalplantohelptheelderlypayforprescrip
Themusicindustry,hurtbyadeclineinCDsalesandthecontinuedfreeswappingoffilesontheInternet,tookthedrasticact
AnavidBushsupporterwhoalreadyhas25shoppingmallstohisname,Congelhimselfisnotamanyouwouldexpecttoentertain
In1969,theNationalWildlifeFederationbegantorecordanindexofenvironmentalqualitywhichmeasuresprogressordeclinei
Computers,andespeciallyconnectingtotheInternet,provideuniqueopportunitiestoenhancescienceandmatheducation.Tak
随机试题
一个人有n把钥匙,其中只有1把钥匙能打开房门,随机逐个试验,则不超过k次打开房门的概率为()。
阅读下面的文字:齐人有冯谖者,贫乏不能自存,使人属孟尝君,愿寄食门下。孟尝君曰:“客何好?”曰:“客无好也。”曰:“客何能?”曰:“客无能也。”孟尝君笑而受之,曰:“诺。”左右以君贱之也,食以草具。居有顷,倚柱弹其剑,歌曰:“长铗归来乎!食无鱼。
密啶核苷合成途径中,首先出现的是
下列关于风险管理和商业银行经营关系的说法不正确的是()
《国家中长期教育改革和发展规划纲要(2010一2020年)》提出,要将减轻中小学生课业负担作为教育工作的重要任务。为切实减轻学生课业负担,各级政府可以采取的措施有()。
在改革和发展中社会主义国有经济的主导作用主要体现在:()
下图所示为一种数字签名方案,网上传送的报文是(43),防止A抵赖的证据是(44)。 (44)
对关键码集合K={53,30,37,12,45,24,96},从空二叉树开始逐个插入每个关键码,建立与集合K相对应的二叉排序树(又称二叉查找树)BST,若希望得到的BST高度最小,应选择的输入序列的是()。
HowmanykindsofdoctorsarethereintheUS?______
5WeekstoaStress-FreeLife[A]Whowillyoubethisyear?Willyoubeabetter,wiserversionofyourselfbythetimethe
最新回复
(
0
)